Journal
AUTOIMMUNITY REVIEWS
Volume 6, Issue 5, Pages 312-314Publisher
ELSEVIER
DOI: 10.1016/j.autrev.2006.09.005
Keywords
vaccination; pneumovax; RA; SLE
Categories
Ask authors/readers for more resources
Vaccination against streptococcus pneumonia is currently recommended for patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Safety and efficacy issues of vaccination in patients suffering from rheumatic diseases are still unresolved. This review summarizes the studies performed on the safety and immunogenicity of pneumococcal vaccination in patients with RA and SLE, with special emphasis on the effect of immunosuppressive drugs on the efficacy of the vaccine. Several trials have shown that the vaccine does not induce clinical exacerbation of RA and that it does induce an adequate Immoral response, albeit one lower than that in healthy controls. (C) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available